Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
None listed
Sponsors
Dr.Payal Maheriya
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients having one or more abnormal lipid levels in their lipid profile investigation. 2.Individuals willing to participate in the clinical trial and provide informed consent. 3.Patient willing to discontinue Anti-lipidemic drug during research study. 4.Lipid profile ranges included for patient selection are as follows:(As per NCEP ATP 3 Guideline) Serum Cholesterol: 200-239 mg/dL and above 240 mg/dL Serum Triglyceride: between 150-499 mg/dL Serum LDL between 130-189 mg/dL Serum HDL between 10-40 mg/dL 5. BMI less than30 kg/m2
Exclusion criteria
Exclusion criteria: 1)Pregnant and lactating women. 2) Patients suffering from acute or chronic major illness which may interferes the study result. 3) Patients with very high levels of cholesterol, specifically: Total Cholesterol: greater than 400 mg/dL Serum Triglyceride: greater than 500 mg/dL Serum LDL Cholesterol: greater than 190 mg/dl 4)BMI greater than 30 kg/m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amrutadi Lipicare may show a positive impact on the lipid profile of patients with Dyslipidaemia.Timepoint: 2 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| Amrutadi Lipicare may demonstrate a positive impact on the Body Mass Index (BMI) of patients with Dyslipidaemia.Timepoint: 2 Months | — |
Countries
India
Contacts
Public ContactDr Payal Maheriya
G J Patel Institute of Ayurvedic Studies & Research
Outcome results
None listed